Clinical trial
A Multi-center, Randomized, Double-blind, Placebo/Positive Parallel Phase III Clinical Trial to Evaluate the Efficacy and Safety of SAL067 in Type 2 Diabetes Patients Who Cannot Effectively Control Blood Glucose Through Diet and Exercise
NCT05782192 is registered in ClinicalTrials.gov with Shenzhen Salubris Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind, Placebo/Positive Parallel Phase III Clinical Trial to Evaluate the Efficacy and Safety of SAL067 in Type 2 Diabetes Patients Who Cannot Effectively Control Blood Glucose Through Diet and Exercise
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 13, 2019
- Completion date
- March 25, 2022
- Enrollment
- 458 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.